Law360, New York (August 26, 2009) -- Massachusetts Attorney General Martha Coakley has accused Mylan Laboratories Inc. and other pharmaceutical companies of systematically reporting false and inflated prices for products purchased by the state's Medicaid program that resulted in millions of dollars in overpayments by taxpayers.
In a second amended complaint filed Tuesday in the U.S. District Court District of Massachusetts, Coakley alleged that the drugmakers committed common law fraud, violated the Massachusetts False Claims Act...
